Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1968-1-21
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0366-1334
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
19
|
| pubmed:volume |
118
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
717-22
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:6060517-Adult,
pubmed-meshheading:6060517-Antiprotozoal Agents,
pubmed-meshheading:6060517-Arsenicals,
pubmed-meshheading:6060517-Dimercaprol,
pubmed-meshheading:6060517-Female,
pubmed-meshheading:6060517-Glucocorticoids,
pubmed-meshheading:6060517-Humans,
pubmed-meshheading:6060517-Trypanosomiasis, African
|
| pubmed:year |
1967
|
| pubmed:articleTitle |
[Trypanosomal meningo-encephalitis observed in France. Reflections concerning the use of arsobal].
|
| pubmed:publicationType |
Journal Article
|